PTCT
PTC Therapeutics Inc
63.70$
+0.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.4% | -32.7% | 33.7% | -38.3% | -39.1% | -14.1% | 74.0% | -32.6% | -31.4% | -20.8% | -21.7% | 35.8% | -3.0% | |
| 31.6% | 26.3% | 26.4% | 3.8% | 3.3% | 3.2% | 0.6% | 4.2% | 5.3% | 7.8% | 5.7% | 4.4% | 5.5% | |
| 13.7% | 5.4% | 8.7% | 10.3% | 10.0% | 8.1% | 1.5% | 10.4% | 9.2% | 11.2% | 8.6% | 6.5% | 8.4% | |
| 3.8% | -26.9% | 31.2% | -6.0% | 5.9% | 17.2% | -3.2% | -9.3% | -40.2% | 55.3% | -40.6% | 2.8% | -9.3% | |
| 14.9% | 9.3% | 30.6% | 4.0% | 5.5% | 3.0% | 0.2% | 2.2% | 121.4% | 22.6% | 0.5% | 2.0% | 29.9% | |
| -15.1% | -30.7% | -54.7% | -35.3% | -21.7% | 125.6% | -15.7% | -235.9% | -137.3% | 20.7% | -34.4% | -34.0% | -46.8% | |
| – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | -0.8% | 0.0% | – | – | – | |
| 1.7% | 202.1% | 0.3% | 132.0% | -9.0% | 12.4% | 0.8% | 2.2% | 7.2% | 183.7% | 2.3% | 58.8% | 53.1% | |
| -21.9% | 139.7% | -21.7% | 55.7% | -65.4% | 119.9% | 59.6% | -258.7% | -164.3% | 189.5% | -54.3% | 59.9% | 3.3% | |
| -22.2% | -41.9% | 3.1% | -34.3% | -44.6% | -17.1% | 73.8% | -34.8% | -152.9% | -43.5% | -22.2% | 33.8% | -33.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.